Owen M Peters - Publications

Cardiff University, Cardiff, Wales, United Kingdom 

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ninkina N, Millership SJ, Peters OM, Connor-Robson N, Chaprov K, Kopylov AT, Montoya A, Kramer H, Withers DJ, Buchman VL. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins. The Journal of Biological Chemistry. 101375. PMID 34736896 DOI: 10.1016/j.jbc.2021.101375  0.632
2021 Peters OM, Smith GA. A nod and a Wnk to axon branching and destruction. Neuron. 109: 2799-2802. PMID 34534451 DOI: 10.1016/j.neuron.2021.08.027  0.745
2021 Peters OM, Weiss A, Metterville J, Song L, Logan R, Smith GA, Schwarzschild MA, Mueller C, Brown RH, Freeman M. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease. Neurobiology of Disease. 105368. PMID 33892050 DOI: 10.1016/j.nbd.2021.105368  0.72
2020 Hsu JM, Kang Y, Corty MM, Mathieson D, Peters OM, Freeman MR. Injury-Induced Inhibition of Bystander Neurons Requires dSarm and Signaling from Glia. Neuron. PMID 33296670 DOI: 10.1016/j.neuron.2020.11.012  0.581
2019 Malik BR, Maddison DC, Smith GA, Peters OM. Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Molecular Brain. 12: 100. PMID 31783880 DOI: 10.1186/S13041-019-0504-X  0.746
2019 Kant S, Craige SM, Chen K, Reif MM, Learnard H, Kelly M, Caliz AD, Tran KV, Ramo K, Peters OM, Freeman M, Davis RJ, Keaney JF. Neural JNK3 regulates blood flow recovery after hindlimb ischemia in mice via an Egr1/Creb1 axis. Nature Communications. 10: 4223. PMID 31530804 DOI: 10.1038/S41467-019-11982-4  0.483
2018 Peters OM, Lewis EA, Osterloh JM, Weiss A, Salameh JS, Metterville J, Brown RH, Freeman MR. Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Human Molecular Genetics. PMID 30010873 DOI: 10.1093/Hmg/Ddy260  0.691
2018 White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, Stephenson J, Yang S, Massenzio F, Lin Z, Andrews S, Segonds-Pichon A, Metterville J, Saksida LM, Mead R, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nature Neuroscience. PMID 29556029 DOI: 10.1038/S41593-018-0113-5  0.495
2016 Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T, Basnakian AG, Calingasan NY, Klessner JL, Flint Beal M, Peters OM, et al. Mutant Profilin1 Transgenic Mice Recapitulate Cardinal Features of Motor Neuron Disease. Human Molecular Genetics. PMID 28040732 DOI: 10.1093/Hmg/Ddw429  0.569
2016 Connor-Robson N, Peters OM, Millership S, Ninkina N, Buchman VL. Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism. Neurobiology of Aging. 46: 107-112. PMID 27614017 DOI: 10.1016/j.neurobiolaging.2016.06.020  0.626
2015 Peters OM, Cabrera GT, Tran H, Gendron TF, McKeon JE, Metterville J, Weiss A, Wightman N, Salameh J, Kim J, Sun H, Boylan KB, Dickson D, Kennedy Z, Lin Z, et al. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Neuron. 88: 902-909. PMID 26637797 DOI: 10.1016/J.Neuron.2015.11.018  0.472
2015 Peters OM, Ghasemi M, Brown RH. Emerging mechanisms of molecular pathology in ALS. The Journal of Clinical Investigation. 125: 2548. PMID 26030230 DOI: 10.1172/JCI82693  0.351
2015 Peters OM, Ghasemi M, Brown RH. Emerging mechanisms of molecular pathology in ALS. The Journal of Clinical Investigation. 125: 1767-79. PMID 25932674 DOI: 10.1172/Jci71601  0.446
2014 Peters OM, Shelkovnikova T, Highley JR, Cooper-Knock J, Hortobágyi T, Troakes C, Ninkina N, Buchman VL. Gamma-synuclein pathology in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 2: 29-37. PMID 25642432 DOI: 10.1002/acn3.143  0.688
2013 Shelkovnikova TA, Peters OM, Deykin AV, Connor-Robson N, Robinson H, Ustyugov AA, Bachurin SO, Ermolkevich TG, Goldman IL, Sadchikova ER, Kovrazhkina EA, Skvortsova VI, Ling SC, Da Cruz S, Parone PA, et al. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. The Journal of Biological Chemistry. 288: 25266-74. PMID 23867462 DOI: 10.1074/Jbc.M113.492017  0.7
2013 Peters OM, Shelkovnikova T, Tarasova T, Springe S, Kukharsky MS, Smith GA, Brooks S, Kozin SA, Kotelevtsev Y, Bachurin SO, Ninkina N, Buchman VL. Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic mice. Journal of Alzheimer's Disease : Jad. 36: 589-96. PMID 23645096 DOI: 10.3233/Jad-130071  0.7
2013 Peters OM, Connor-Robson N, Sokolov VB, Aksinenko AY, Kukharsky MS, Bachurin SO, Ninkina N, Buchman VL. Chronic administration of dimebon ameliorates pathology in TauP301S transgenic mice. Journal of Alzheimer's Disease : Jad. 33: 1041-9. PMID 23099813 DOI: 10.3233/JAD-2012-121732  0.599
2012 Ninkina N, Peters OM, Connor-Robson N, Lytkina O, Sharfeddin E, Buchman VL. Contrasting effects of α-synuclein and γ-synuclein on the phenotype of cysteine string protein α (CSPα) null mutant mice suggest distinct function of these proteins in neuronal synapses. The Journal of Biological Chemistry. 287: 44471-7. PMID 23129765 DOI: 10.1074/jbc.M112.422402  0.626
2012 Peters OM, Millership S, Shelkovnikova TA, Soto I, Keeling L, Hann A, Marsh-Armstrong N, Buchman VL, Ninkina N. Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis. Neurobiology of Disease. 48: 124-31. PMID 22750530 DOI: 10.1016/j.nbd.2012.06.016  0.697
2011 Bachurin SO, Shelkovnikova TA, Ustyugov AA, Peters O, Khritankova I, Afanasieva MA, Tarasova TV, Alentov II, Buchman VL, Ninkina NN. Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice. Neurotoxicity Research. 22: 33-42. PMID 22179976 DOI: 10.1007/s12640-011-9299-y  0.682
2011 Anwar S, Peters O, Millership S, Ninkina N, Doig N, Connor-Robson N, Threlfell S, Kooner G, Deacon RM, Bannerman DM, Bolam JP, Chandra SS, Cragg SJ, Wade-Martins R, Buchman VL. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 7264-74. PMID 21593311 DOI: 10.1523/Jneurosci.6194-10.2011  0.651
2011 Shelkovnikova TA, Ustyugov AA, Millership S, Peters O, Anichtchik O, Spillantini MG, Buchman VL, Bachurin SO, Ninkina NN. Dimebon does not ameliorate pathological changes caused by expression of truncated (1-120) human alpha-synuclein in dopaminergic neurons of transgenic mice. Neuro-Degenerative Diseases. 8: 430-7. PMID 21576917 DOI: 10.1159/000324989  0.67
2009 Ninkina N, Peters O, Millership S, Salem H, van der Putten H, Buchman VL. Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein. Human Molecular Genetics. 18: 1779-94. PMID 19246516 DOI: 10.1093/hmg/ddp090  0.669
Show low-probability matches.